Controversies in the cellular pharmacology of oligodeoxynucleotides.
Stein
C A
CA
Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002461:Cell Line, Transformed; D002463:Cell Membrane Permeability; D004705:Endocytosis; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000494:pharmacology; D008247:Lysosomes; D051379:Mice; D009838:Oligodeoxyribonucleotides / Q000493:pharmacokinetics*; D016376:Oligonucleotides, Antisense / Q000493:pharmacokinetics; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology; D011956:Receptors, Cell Surface / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000378:metabolism; D000099221:Protein Kinase C zeta
D004791:Enzyme Inhibitors; D019787:Linoleic Acid; D008041:Linoleic Acids; D009838:Oligodeoxyribonucleotides; D016376:Oligonucleotides, Antisense; D011493:Protein Kinase C; D011956:Receptors, Cell Surface; D000099221:Protein Kinase C zeta